Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
10 pending office actions • 10 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days
University of Kansas has 12 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 12 distinct examiners and 12 distinct art units, showing that each pending action has its own examiner and art-unit assignment. The profile therefore reflects broad administrative distribution rather than concentration in a shared examination setting.
IP, JASON M is the busiest examiner listed, with 1 pending matter. Because no examiner holds more than that listed share, counsel should use a distributed docket-management approach. Centralized review can preserve consistent disclosure and claim positions, while response preparation remains tailored to the separate examiner and art-unit contexts.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 4 (40%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IP, JASON M | 1 | 55.5% | +24.9% |
| MELLER, MICHAEL V | 1 | 47.2% | +28.0% |
| BARSKY, JARED | 1 | 50.3% | +22.8% |
| CRUM, VIVIAN FLORENCE | 1 | 100.0% | +0.0% |
| CARR, DEBORAH D | 1 | 81.8% | +2.9% |
| KIM, EUNHEE | 1 | 77.3% | +12.2% |
| HOFFMAN, ALEXANDER JOSEPH | 1 | 0.0% | +0.0% |
| NGUYEN, BOI-LIEN THI | 1 | 23.4% | +30.3% |
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
| LOPEZLIRA, ASHLEY NICOLE | 1 | 70.2% | +36.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18537021 | FORWARD OSMOSIS PROCESS TO INCREASE THE CONCENTRATION OF A DILUTE METAL SALT SOLUTION AND RELATED PROCESSES | CRUM, VIVIAN FLORENCE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278329 | HYDROXYLATION OF ALKANES USING OZONE | CARR, DEBORAH D | 2d overdue |
| 18779564 | TREATMENT OF INCLUSION BODY MYOSITIS WITH ADIPOSE-DERIVED REGENERATIVE CELLS | MELLER, MICHAEL V | — |
| 18253520 | ALGORITHMS FOR PREDICTING VUG CONNECTIVITY | KIM, EUNHEE | — |
| 18185164 | CXCL14 AS PREDICTIVE BIOMARKER FOR ACUTE LIVER FAILURE AND DEATH | HOFFMAN, ALEXANDER JOSEPH | — |
| 16235442 | APPARATUS, SYSTEMS, AND METHODS FOR ISOTOPE EXCHANGE AND/OR DIALYSIS | NGUYEN, BOI-LIEN THI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18865299 | DEVICES, SYSTEMS, AND METHODS FOR ULTRASOUND THERAPY | IP, JASON M | — |
| 18779564 | TREATMENT OF INCLUSION BODY MYOSITIS WITH ADIPOSE-DERIVED REGENERATIVE CELLS | MELLER, MICHAEL V | — |
| 18770447 | TREATMENT OF INCLUSION BODY MYOSITIS WITH PHENYLBUTYRATE AND MONITORING OF TREATMENT | BARSKY, JARED | — |
| 18253520 | ALGORITHMS FOR PREDICTING VUG CONNECTIVITY | KIM, EUNHEE | — |
| 16235442 | APPARATUS, SYSTEMS, AND METHODS FOR ISOTOPE EXCHANGE AND/OR DIALYSIS | NGUYEN, BOI-LIEN THI | — |
| 18683240 | CROSS-LINKED POLYMERIC CHELATORS COMPOSITIONS AND USE THEREOF | ARMSTRONG, SUSANNAH SIPPLE | — |
| 17560870 | FERROMAGNETIC MATERIAL WITH REMOTE RESPONSIVE CONTROL FOR DYNAMIC CELL CULTURE | LOPEZLIRA, ASHLEY NICOLE | — |
| Art Unit | Apps |
|---|---|
| 3792 | 1 |
| 1655 | 1 |
| 1628 | 1 |
| 1738 | 1 |
| 1691 | 1 |
| 2188 | 1 |
| 1677 | 1 |
| 1779 | 1 |
| 1616 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18865299 | DEVICES, SYSTEMS, AND METHODS FOR ULTRASOUND THERAPY | IP, JASON M | 3792 | §103 | Final Rejection | — | Pending | Nov 12, 2024 |
| 18779564 | TREATMENT OF INCLUSION BODY MYOSITIS WITH ADIPOSE-DERIVED REGENERATIVE CELLS | MELLER, MICHAEL V | 1655 | §102§103 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18770447 | TREATMENT OF INCLUSION BODY MYOSITIS WITH PHENYLBUTYRATE AND MONITORING OF TREATMENT | BARSKY, JARED | 1628 | §103 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18537021 | FORWARD OSMOSIS PROCESS TO INCREASE THE CONCENTRATION OF A DILUTE METAL SALT SOLUTION AND RELATED PROCESSES | CRUM, VIVIAN FLORENCE | 1738 | §103 | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18278329 | HYDROXYLATION OF ALKANES USING OZONE | CARR, DEBORAH D | 1691 | §103§112 | Non-Final OA | 2d overdue | Pending | Aug 22, 2023 |
| 18253520 | ALGORITHMS FOR PREDICTING VUG CONNECTIVITY | KIM, EUNHEE | 2188 | §102§103§112 | Non-Final OA | — | Pending | May 18, 2023 |
| 18185164 | CXCL14 AS PREDICTIVE BIOMARKER FOR ACUTE LIVER FAILURE AND DEATH | HOFFMAN, ALEXANDER JOSEPH | 1677 | §101§103 | Final Rejection | — | Pending | Mar 16, 2023 |
| 16235442 | APPARATUS, SYSTEMS, AND METHODS FOR ISOTOPE EXCHANGE AND/OR DIALYSIS | NGUYEN, BOI-LIEN THI | 1779 | §103§112 | Non-Final OA | — | Pending | Dec 28, 2018 |
| 18683240 | CROSS-LINKED POLYMERIC CHELATORS COMPOSITIONS AND USE THEREOF | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103§112DP | Non-Final OA | — | Pending | Feb 12, 2024 |
| 17560870 | FERROMAGNETIC MATERIAL WITH REMOTE RESPONSIVE CONTROL FOR DYNAMIC CELL CULTURE | LOPEZLIRA, ASHLEY NICOLE | 1799 | §103 | Final Rejection | — | Pending | Dec 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Kansas has 10 pending office actions as of October 2026, spread across 10 art units and 10 examiners.
Jason M Ip has the most, with 1 of University of Kansas's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
